Treatment of breast cancer patients by neoadjuvant systemic therapy has traditionally been used to treat locally advanced inoperable and inflammatory cancers or preceding breast conserving surgery [1]. A recent pooled analysis from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC) international working group demonstrated that pathologic complete responses (pCR) are correlated with better long term outcomes (event free survival and overall survival [OS]). This was particularly true for the more aggressive breast cancer subtypes (i.e.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qqftyz
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Excerpt from Common Culture: Reading and Writing About American Popular Culture. Ed. Michael Petracca, Madeleine Sorapure. Upper Saddle Rive...
-
Robert Schumann regnes som en av de store romantiske komponistene, særlig anerkjent er hans klaver- og kammermusikk. Han startet på utdanni...
-
Thesis Statement Creator: Directions: This web page explains the different parts to a thesis statement and helps you create your own. You ca...
-
Effect of titanium oxide and zirconium oxide nanoparticle incorporation on the flexural strength of heat-activated polymethyl methacrylate d...
-
Abstract Objectives Patients undergoing osteoporosis treatment benefit greatly from early detection. We previously developed a computer-...
-
Publication date: Available online 20 March 2018 Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology Author(s): Tobia...
-
Related Articles Return of Genetic Research Results to Participants and Families: IRB Perspectives and Roles. J Law Med Ethics. 2015;...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου